ACTINOGEN MEDICAL LIMITED - Announcements

3.70%

2.8¢

Market Cap $88.91M

Healthcare Biotechnology

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight

Actinogen reaches 100th participant milestone

Announcements

Filter Results

All Price Sensitive Only

ACW	Application for quotation of securities - ACW		29/08/25	15.5KB	Share
ACW	Notification of cessation of securities - ACW		26/08/25	12.73KB	Share
ACW	ACW pharmacokinetics trial success	PRICE SENSITIVE	26/08/25	239.79KB	Share
ACW	Appendix 4G		25/08/25	314.53KB	Share
ACW	Corporate Governance Statement		25/08/25	371.01KB	Share
ACW	ACW FY2025 results - accelerating Alzheimers pivotal trial	PRICE SENSITIVE	25/08/25	256.71KB	Share
ACW	ACW Appendix 4E and 2025 annual report	PRICE SENSITIVE	25/08/25	5.81MB	Share
ACW	ACW CEO Q&A at Bioshares 2025		07/08/25	1.5MB	Share
ACW	Actinogen June 2025 quarterly activity report & Appendix 4C	PRICE SENSITIVE	30/07/25	603.58KB	Share
ACW	Notification of buy-back - ACW		30/07/25	12.66KB	Share
ACW	ACW presents key clinical data at AAIC dementia meeting		28/07/25	560.61KB	Share
ACW	ACW accesses up to $13.8m in non-dilutive R&D tax funding	PRICE SENSITIVE	30/06/25	262.03KB	Share
ACW	ACW 100th AD trial participant & interim analysis timeline	PRICE SENSITIVE	30/06/25	269.25KB	Share
ACW	ACW presents at BIO international partnering conference		16/06/25	1.21MB	Share
ACW	Ceasing to be a substantial holder		21/05/25	137.72KB	Share
ACW	Actinogen CMO presents positive depression data at APA 2025		19/05/25	441.55KB	Share
ACW	ACW Science Forum today - Preparing for commercialization		15/05/25	1.88MB	Share
ACW	Actinogen March 2025 quarterly activity report & Appendix 4C	PRICE SENSITIVE	30/04/25	512.41KB	Share
ACW	ACW Science Forum notice - Preparing for commercialization		24/04/25	219.93KB	Share
ACW	Change in substantial holding		23/04/25	216.67KB	Share
ACW	ACW CMO presents Xanamem pTau poster at ADPD25 conference		02/04/25	604.16KB	Share
ACW	ACW conducts Type C meeting with FDA regarding depression	PRICE SENSITIVE	27/03/25	236.28KB	Share
ACW	Actinogen presentation to ASX small & mid-caps conference		26/03/25	1.38MB	Share
ACW	Appendix 3Ys x 5		24/03/25	359.07KB	Share
ACW	Notification of cessation of securities - ACW		24/03/25	12.78KB	Share
ACW	Notification of cessation of securities - ACW		24/03/25	12.83KB	Share
ACW	Application for quotation of securities - ACW		24/03/25	18.02KB	Share
ACW	Results of Meeting		14/03/25	280.27KB	Share
ACW	Notification of buy-back - ACW		04/03/25	12.66KB	Share
ACW	ACW HY25 results Advancing to latestage clinical development	PRICE SENSITIVE	24/02/25	274.84KB	Share
ACW	Actinogen HY2025 financial report and Appendix 4D	PRICE SENSITIVE	24/02/25	1.9MB	Share
ACW	Letter to Shareholders, Notice of GM & Proxy Form		10/02/25	587.74KB	Share
ACW	Peer-reviewed clinpharm manuscript published	PRICE SENSITIVE	06/02/25	253.79KB	Share
ACW	Application for quotation of securities - ACW		30/01/25	15.53KB	Share
ACW	ACW December 2024 quarterly activity report & Appendix 4C	PRICE SENSITIVE	29/01/25	558.42KB	Share
ACW	ACW presents at Sachs Neuro & WHO grants INN emestedastat		13/01/25	1.58MB	Share
ACW	Change in substantial holding		19/12/24	162.59KB	Share
ACW	Application for quotation of securities - ACW		16/12/24	17.85KB	Share
ACW	ACW to list $0.05 options exp 31 May 2027 - ASX code ACWOD		13/12/24	238.28KB	Share
ACW	Listed Options Top 20 & Distribution Schedule		13/12/24	142.62KB	Share
ACW	Application for quotation of securities - ACW		13/12/24	18.86KB	Share
ACW	ACW randomizes first US participant in Alzheimers trial	PRICE SENSITIVE	09/12/24	239.69KB	Share
ACW	Application for quotation of securities - ACW		05/12/24	15.54KB	Share
ACW	Notification of cessation of securities - ACW		03/12/24	12.79KB	Share
ACW	Notification of cessation of securities - ACW		28/11/24	12.8KB	Share
ACW	Results of Annual General Meeting		14/11/24	235.94KB	Share
ACW	Actinogen 2024 AGM, Chairs address and CEOs presentation		14/11/24	1.78MB	Share
ACW	Actinogen receives $9.0 million R&D tax incentive rebate	PRICE SENSITIVE	12/11/24	210.91KB	Share
ACW	Notification of buy-back - ACW		06/11/24	12.67KB	Share
ACW	Appendix 3Ys x 4		04/11/24	258.93KB	Share
ACW	Cleansing Notice		04/11/24	316.37KB	Share
ACW	Application for quotation of securities - ACW		04/11/24	17.92KB	Share
ACW	Application for quotation of securities - ACW		04/11/24	17.93KB	Share
ACW	Results of General Meeting		04/11/24	236.22KB	Share
ACW	ACW CMO presents academic poster at CTAD 2024 conference		31/10/24	577.99KB	Share
ACW	ACW September 2024 quarterly activity report & Appendix 4C	PRICE SENSITIVE	30/10/24	573.58KB	Share
ACW	Issue of SPP shares & attaching listed options following GM		29/10/24	212.62KB	Share
ACW	Actinogen appoints Andrew Udell as Chief Commercial Officer		29/10/24	235.39KB	Share
ACW	Annual Report to Shareholders		11/10/24	5.8MB	Share
ACW	Letter to Shareholders, Notice of AGM & Proxy Form		11/10/24	544.22KB	Share
ACW	ACW Dementia Trials Australia presentation		11/10/24	1.8MB	Share
ACW	$3.0 million share purchase plan closes 1.3x oversubscribed	PRICE SENSITIVE	10/10/24	243.9KB	Share
ACW	Letter to Shareholders & Notice of General Meeting		04/10/24	569.82KB	Share
ACW	Change in substantial holding		26/09/24	159.14KB	Share
ACW	Date of AGM and Closing Date for Director Nominations		25/09/24	207.84KB	Share
ACW	Listed Options Top 20 Holders		24/09/24	73.18KB	Share
ACW	Listed Options Distribution Schedule		24/09/24	69.53KB	Share
ACW	Application for quotation of securities - ACW		24/09/24	19.3KB	Share
ACW	Letter to Ineligible Shareholders		24/09/24	216.76KB	Share
ACW	Letter to Eligible Shareholders		24/09/24	267.05KB	Share
ACW	Update - Application for quotation of securities - ACW		24/09/24	15.5KB	Share
ACW	Cleansing Notice		24/09/24	316.31KB	Share
ACW	Application for quotation of securities - ACW		24/09/24	15.76KB	Share
ACW	Share Purchase Plan & Options Prospectus		20/09/24	461.38KB	Share
ACW	Actinogen CEO presents at Pitt Street Research Conference		19/09/24	1.5MB	Share
ACW	Proposed issue of securities - ACW		18/09/24	23.57KB	Share
ACW	Proposed issue of securities - ACW		18/09/24	19.19KB	Share
ACW	Proposed issue of securities - ACW		18/09/24	18.84KB	Share
ACW	ACW $11.1m capital raising to accelerate Alzheimers trial	PRICE SENSITIVE	18/09/24	1.6MB	Share
ACW	Trading Halt	PRICE SENSITIVE	16/09/24	661.05KB	Share
ACW	Pause in Trading	PRICE SENSITIVE	16/09/24	116.14KB	Share
ACW	Application for quotation of securities - ACW		11/09/24	15.51KB	Share
ACW	Application for quotation of securities - ACW		05/09/24	15.51KB	Share
ACW	Appendix 4G		30/08/24	286.27KB	Share
ACW	Corporate Governance Statement		30/08/24	372.5KB	Share
ACW	ACW FY2024 results, advancing into late-stage trials	PRICE SENSITIVE	30/08/24	257.96KB	Share
ACW	ACW Appendix 4E and 2024 Annual Report	PRICE SENSITIVE	30/08/24	5.91MB	Share
ACW	ACW updated positive depression trial results presentation		29/08/24	1.28MB	Share
ACW	ACW updated depression trial results and implications	PRICE SENSITIVE	26/08/24	258.85KB	Share
ACW	Application for quotation of securities - ACW		13/08/24	17.95KB	Share
ACW	ACW XanaCIDD phase 2a trial topline results	PRICE SENSITIVE	12/08/24	1.1MB	Share
ACW	Trading Halt	PRICE SENSITIVE	08/08/24	664.71KB	Share
ACW	Application for quotation of securities - ACW		31/07/24	20.4KB	Share
ACW	ACW CMO presents academic poster at AAIC in Philadelphia		29/07/24	2.52MB	Share
ACW	Application for quotation of securities - ACW		25/07/24	17.96KB	Share
ACW	Application for quotation of securities - ACW		24/07/24	17.96KB	Share
ACW	ACW June 2024 quarterly activity report & Appendix 4C	PRICE SENSITIVE	22/07/24	590.63KB	Share
ACW	Application for quotation of securities - ACW		19/07/24	17.96KB	Share
ACW	Application for quotation of securities - ACW		18/07/24	17.96KB	Share
ACW	Application for quotation of securities - ACW		17/07/24	17.96KB	Share

ACW Application for quotation of securities - ACW
29/08/25		15.5KB	Share
ACW Notification of cessation of securities - ACW
26/08/25		12.73KB	Share
ACW ACW pharmacokinetics trial success
26/08/25	PRICE SENSITIVE	239.79KB	Share
ACW Appendix 4G
25/08/25		314.53KB	Share
ACW Corporate Governance Statement
25/08/25		371.01KB	Share
ACW ACW FY2025 results - accelerating Alzheimers pivotal trial
25/08/25	PRICE SENSITIVE	256.71KB	Share
ACW ACW Appendix 4E and 2025 annual report
25/08/25	PRICE SENSITIVE	5.81MB	Share
ACW ACW CEO Q&A at Bioshares 2025
07/08/25		1.5MB	Share
ACW Actinogen June 2025 quarterly activity report & Appendix 4C
30/07/25	PRICE SENSITIVE	603.58KB	Share
ACW Notification of buy-back - ACW
30/07/25		12.66KB	Share
ACW ACW presents key clinical data at AAIC dementia meeting
28/07/25		560.61KB	Share
ACW ACW accesses up to $13.8m in non-dilutive R&D tax funding
30/06/25	PRICE SENSITIVE	262.03KB	Share
ACW ACW 100th AD trial participant & interim analysis timeline
30/06/25	PRICE SENSITIVE	269.25KB	Share
ACW ACW presents at BIO international partnering conference
16/06/25		1.21MB	Share
ACW Ceasing to be a substantial holder
21/05/25		137.72KB	Share
ACW Actinogen CMO presents positive depression data at APA 2025
19/05/25		441.55KB	Share
ACW ACW Science Forum today - Preparing for commercialization
15/05/25		1.88MB	Share
ACW Actinogen March 2025 quarterly activity report & Appendix 4C
30/04/25	PRICE SENSITIVE	512.41KB	Share
ACW ACW Science Forum notice - Preparing for commercialization
24/04/25		219.93KB	Share
ACW Change in substantial holding
23/04/25		216.67KB	Share
ACW ACW CMO presents Xanamem pTau poster at ADPD25 conference
02/04/25		604.16KB	Share
ACW ACW conducts Type C meeting with FDA regarding depression
27/03/25	PRICE SENSITIVE	236.28KB	Share
ACW Actinogen presentation to ASX small & mid-caps conference
26/03/25		1.38MB	Share
ACW Appendix 3Ys x 5
24/03/25		359.07KB	Share
ACW Notification of cessation of securities - ACW
24/03/25		12.78KB	Share
ACW Notification of cessation of securities - ACW
24/03/25		12.83KB	Share
ACW Application for quotation of securities - ACW
24/03/25		18.02KB	Share
ACW Results of Meeting
14/03/25		280.27KB	Share
ACW Notification of buy-back - ACW
04/03/25		12.66KB	Share
ACW ACW HY25 results Advancing to latestage clinical development
24/02/25	PRICE SENSITIVE	274.84KB	Share
ACW Actinogen HY2025 financial report and Appendix 4D
24/02/25	PRICE SENSITIVE	1.9MB	Share
ACW Letter to Shareholders, Notice of GM & Proxy Form
10/02/25		587.74KB	Share
ACW Peer-reviewed clinpharm manuscript published
06/02/25	PRICE SENSITIVE	253.79KB	Share
ACW Application for quotation of securities - ACW
30/01/25		15.53KB	Share
ACW ACW December 2024 quarterly activity report & Appendix 4C
29/01/25	PRICE SENSITIVE	558.42KB	Share
ACW ACW presents at Sachs Neuro & WHO grants INN emestedastat
13/01/25		1.58MB	Share
ACW Change in substantial holding
19/12/24		162.59KB	Share
ACW Application for quotation of securities - ACW
16/12/24		17.85KB	Share
ACW ACW to list $0.05 options exp 31 May 2027 - ASX code ACWOD
13/12/24		238.28KB	Share
ACW Listed Options Top 20 & Distribution Schedule
13/12/24		142.62KB	Share
ACW Application for quotation of securities - ACW
13/12/24		18.86KB	Share
ACW ACW randomizes first US participant in Alzheimers trial
09/12/24	PRICE SENSITIVE	239.69KB	Share
ACW Application for quotation of securities - ACW
05/12/24		15.54KB	Share
ACW Notification of cessation of securities - ACW
03/12/24		12.79KB	Share
ACW Notification of cessation of securities - ACW
28/11/24		12.8KB	Share
ACW Results of Annual General Meeting
14/11/24		235.94KB	Share
ACW Actinogen 2024 AGM, Chairs address and CEOs presentation
14/11/24		1.78MB	Share
ACW Actinogen receives $9.0 million R&D tax incentive rebate
12/11/24	PRICE SENSITIVE	210.91KB	Share
ACW Notification of buy-back - ACW
06/11/24		12.67KB	Share
ACW Appendix 3Ys x 4
04/11/24		258.93KB	Share
ACW Cleansing Notice
04/11/24		316.37KB	Share
ACW Application for quotation of securities - ACW
04/11/24		17.92KB	Share
ACW Application for quotation of securities - ACW
04/11/24		17.93KB	Share
ACW Results of General Meeting
04/11/24		236.22KB	Share
ACW ACW CMO presents academic poster at CTAD 2024 conference
31/10/24		577.99KB	Share
ACW ACW September 2024 quarterly activity report & Appendix 4C
30/10/24	PRICE SENSITIVE	573.58KB	Share
ACW Issue of SPP shares & attaching listed options following GM
29/10/24		212.62KB	Share
ACW Actinogen appoints Andrew Udell as Chief Commercial Officer
29/10/24		235.39KB	Share
ACW Annual Report to Shareholders
11/10/24		5.8MB	Share
ACW Letter to Shareholders, Notice of AGM & Proxy Form
11/10/24		544.22KB	Share
ACW ACW Dementia Trials Australia presentation
11/10/24		1.8MB	Share
ACW $3.0 million share purchase plan closes 1.3x oversubscribed
10/10/24	PRICE SENSITIVE	243.9KB	Share
ACW Letter to Shareholders & Notice of General Meeting
04/10/24		569.82KB	Share
ACW Change in substantial holding
26/09/24		159.14KB	Share
ACW Date of AGM and Closing Date for Director Nominations
25/09/24		207.84KB	Share
ACW Listed Options Top 20 Holders
24/09/24		73.18KB	Share
ACW Listed Options Distribution Schedule
24/09/24		69.53KB	Share
ACW Application for quotation of securities - ACW
24/09/24		19.3KB	Share
ACW Letter to Ineligible Shareholders
24/09/24		216.76KB	Share
ACW Letter to Eligible Shareholders
24/09/24		267.05KB	Share
ACW Update - Application for quotation of securities - ACW
24/09/24		15.5KB	Share
ACW Cleansing Notice
24/09/24		316.31KB	Share
ACW Application for quotation of securities - ACW
24/09/24		15.76KB	Share
ACW Share Purchase Plan & Options Prospectus
20/09/24		461.38KB	Share
ACW Actinogen CEO presents at Pitt Street Research Conference
19/09/24		1.5MB	Share
ACW Proposed issue of securities - ACW
18/09/24		23.57KB	Share
ACW Proposed issue of securities - ACW
18/09/24		19.19KB	Share
ACW Proposed issue of securities - ACW
18/09/24		18.84KB	Share
ACW ACW $11.1m capital raising to accelerate Alzheimers trial
18/09/24	PRICE SENSITIVE	1.6MB	Share
ACW Trading Halt
16/09/24	PRICE SENSITIVE	661.05KB	Share
ACW Pause in Trading
16/09/24	PRICE SENSITIVE	116.14KB	Share
ACW Application for quotation of securities - ACW
11/09/24		15.51KB	Share
ACW Application for quotation of securities - ACW
05/09/24		15.51KB	Share
ACW Appendix 4G
30/08/24		286.27KB	Share
ACW Corporate Governance Statement
30/08/24		372.5KB	Share
ACW ACW FY2024 results, advancing into late-stage trials
30/08/24	PRICE SENSITIVE	257.96KB	Share
ACW ACW Appendix 4E and 2024 Annual Report
30/08/24	PRICE SENSITIVE	5.91MB	Share
ACW ACW updated positive depression trial results presentation
29/08/24		1.28MB	Share
ACW ACW updated depression trial results and implications
26/08/24	PRICE SENSITIVE	258.85KB	Share
ACW Application for quotation of securities - ACW
13/08/24		17.95KB	Share
ACW ACW XanaCIDD phase 2a trial topline results
12/08/24	PRICE SENSITIVE	1.1MB	Share
ACW Trading Halt
08/08/24	PRICE SENSITIVE	664.71KB	Share
ACW Application for quotation of securities - ACW
31/07/24		20.4KB	Share
ACW ACW CMO presents academic poster at AAIC in Philadelphia
29/07/24		2.52MB	Share
ACW Application for quotation of securities - ACW
25/07/24		17.96KB	Share
ACW Application for quotation of securities - ACW
24/07/24		17.96KB	Share
ACW ACW June 2024 quarterly activity report & Appendix 4C
22/07/24	PRICE SENSITIVE	590.63KB	Share
ACW Application for quotation of securities - ACW
19/07/24		17.96KB	Share
ACW Application for quotation of securities - ACW
18/07/24		17.96KB	Share
ACW Application for quotation of securities - ACW
17/07/24		17.96KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.8¢		Change 0.001(3.70%)		Mkt cap ! $88.91M

Open	High	Low	Value	Volume
2.8¢	2.8¢	2.7¢	$12.00K	444.5K

Buyers (Bids)

No.	Vol.	Price($)
1	530460	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	1529473	6

View Market Depth

No.	Vol.	Price($)
1	530460	0.027
12	1996115	0.026
11	2380415	0.025
10	2408530	0.024
5	990234	0.023

Price($)	Vol.	No.
0.028	1529473	6
0.029	525000	2
0.030	805084	5
0.031	798418	4
0.032	3770500	6

Last trade - 16.10pm 09/09/2025 (20 minute delay)

ACW (ASX) Chart

ACTINOGEN MEDICAL LIMITED - Announcements

Corporate Spotlight

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories